...Hello, everyone, and welcome to the earnings call for the second quarter of Biovica's broken fiscal year for '23 and '24. So we go on to the next slide. The presenters for today will be first it will be me Anders Rylander, followed by Warren Cresswell, Henrick Winther, and Anders MorTn. And the agenda for the call is a short introduction from me and then I'll talk about the highlights. Then we'll dive into a US update with Warren Cresswell. And Henrik Winther will provide an update about our pharma services development. And Anders MorTn will provide an update about the financial status before we have a summary by me and the Q&A session. And you can all post questions and using the functioning teams. And if you want to remain anonymous, you can do that as well by checking that checkbox. And at the start of the session, we will let the equity researchers in from Redeye, Pareto, and Kempen. So they also would have the opportunity to ask questions -- follow-up questions that we received from...
